BRKR - Bruker Corporation
| Previous Close | 42.89 |
| Open | 42.84 |
| Bid | 0.00 x 800 |
| Ask | 0.00 x 3200 |
| Day's Range | 42.39 - 43.33 |
| 52 Week Range | 26.10 - 51.41 |
| Volume | 558,661 |
| Avg. Volume | 876,601 |
| Market Cap | 6.648B |
| Beta (3Y Monthly) | 1.46 |
| PE Ratio (TTM) | 35.85 |
| EPS (TTM) | 1.20 |
| Earnings Date | Oct 30, 2019 - Nov 4, 2019 |
| Forward Dividend & Yield | 0.16 (0.37%) |
| Ex-Dividend Date | 2019-08-30 |
| 1y Target Est | 50.73 |
- PR Newswire
Bruker Announces Release of Breakthrough diaPASEF Workflow for CCS-aware 4D Proteomics on timsTOF™ Pro Platform at HUPO 2019
- diaPASEF increases protein identifications, sensitivity and data completeness - CCS-aware diaPASEF processing now supported by Mobi-DIK, PEAKS, Spectronaut, MaxQuant and Skyline proteomics software solutions ...
- Zacks
Bruker (BRKR) Introduces the nanoIR3-s Broadband System
The launch of the FTIR spectroscopy system complements Bruker's (BRKR) target to boost its portfolio of nanoIR products.
- PR Newswire
Bruker Launches Nanoscale Infrared Spectroscopy and Chemical Imaging SNOM/AFM Microscopy System with Broadband Femtosecond IR Laser
Most Advanced s-Scanning Near-field Optical Microscopy/Atomic Force Microscopy-IR System Commercially Available AMSTERDAM , Sept. 11, 2019 /PRNewswire/ -- At the 4th Annual European Forum on Nanoscale ...
- GuruFocus.com
Bruker Corp (BRKR) Pres. & CEO, Bruker EST Burkhard Prause Sold $674,558 of Shares
Pres. & CEO, Bruker EST of Bruker Corp (30-Year Financial, Insider Trades) Burkhard Prause (insider trades) sold 15,702 shares of BRKR on 09/05/2019 at an average price of $42.96 a share. Continue reading...
- Simply Wall St.
Need To Know: Bruker Corporation (NASDAQ:BRKR) Insiders Have Been Selling Shares
We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. On...
- Zacks
Bruker (BRKR) Releases JPK NanoWizard 4 XP Bio-AFM System
With the launch of this new system, Bruker (BRKR) establishes a performance yardstick for atomic force microscopy in the field of life science research.
- PR Newswire
Bruker Launches Highest Resolution Large-Format Bio-AFM System
New NanoWizard 4 XP Provides Extreme Imaging Performance and Ease of Use MUENSTER, Germany , Sept. 2, 2019 /PRNewswire/ --At the 9th AFM BioMed Conference, Bruker Corporation (Nasdaq: BRKR) today announced ...
- Zacks
Bruker (BRKR) Down 7.4% Since Last Earnings Report: Can It Rebound?
Bruker (BRKR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- PR Newswire
Bruker Announces World's First 1.2 GHz High-Resolution Protein NMR Data
BERLIN , Aug. 26, 2019 /PRNewswire/ -- At EUROISMAR 2019 ( https://conference.euroismar2019.org ), Bruker Corporation (Nasdaq: BRKR) today announced the world's first 1.2 GHz high-resolution, protein nuclear ...
- Simply Wall St.
Does The Data Make Bruker Corporation (NASDAQ:BRKR) An Attractive Investment?
Attractive stocks have exceptional fundamentals. In the case of Bruker Corporation (NASDAQ:BRKR), there's is a company...
- PR Newswire
Bruker Announces Quarterly Dividend
BILLERICA, Mass. , Aug. 12, 2019 /PRNewswire/ -- Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.04 per ...
- Thomson Reuters StreetEvents
Edited Transcript of BRKR earnings conference call or presentation 1-Aug-19 8:30pm GMT
Q2 2019 Bruker Corp Earnings Call
Motley FoolBruker (BRKR) Q2 2019 Earnings Call Transcript
BRKR earnings call for the period ending June 30, 2019.
- Zacks
Bruker (BRKR) Q2 Earnings Beat Estimates, Margins Expand
Bruker (BRKR) registers strong year-over-year revenue growth across all segments and geographies.
- Zacks
Bruker (BRKR) Beats Q2 Earnings and Revenue Estimates
Bruker (BRKR) delivered earnings and revenue surprises of 6.45% and 2.71%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
- PR Newswire
Bruker Reports Second Quarter 2019 Financial Results
-- Q2-19 revenue growth of 10.5% and organic revenue growth of 4.8% year-over-year -- Q2-19 GAAP EPS of $0.23 ; Q2-19 non-GAAP EPS of $0.33 , up 32% year-over-year -- Confirms FY 2019 revenue growth, non-GAAP ...
- Zacks
Garmin's (GRMN) Q2 Earnings & Revenues Surpass Estimates
Garmin's (GRMN) second-quarter results benefit from strong performance by its fitness, outdoor, marine and aviation segments.
- Simply Wall St.
At US$48.58, Is Bruker Corporation (NASDAQ:BRKR) Worth Looking At Closely?
Bruker Corporation (NASDAQ:BRKR), which is in the life sciences business, and is based in United States, saw a...
- Zacks
Can Bruker (BRKR) Q2 Earnings See BioSpin's Growth Revival?
Bruker (BRKR) expects BioSpin to bode well for better organic growth in Q2.
- Zacks
Is Bruker (BRKR) Outperforming Other Computer and Technology Stocks This Year?
Is (BRKR) Outperforming Other Computer and Technology Stocks This Year?
- Zacks
Bruker (BRKR) Earnings Expected to Grow: Should You Buy?
Bruker (BRKR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- PR Newswire
Bruker Announces Date and Time of Second Quarter 2019 Earnings Release and Webcast
BILLERICA, Mass. , July 23, 2019 /PRNewswire/ -- Bruker Corporation (Nasdaq: BRKR) today announced it will report second quarter 2019 financial results on Thursday, August 1, 2019 , after the market closes. The ...
- PR Newswire
Bruker Comments on Block Trade Transaction
BILLERICA, Mass. , July 17, 2019 /PRNewswire/ -- Bruker Corporation (Nasdaq: BRKR) has been advised that former board member, Mr. Joerg C. Laukien , has authorized a block sale of Bruker shares as part ...
- Zacks
Illumina (ILMN) Grows on Innovation & International Growth
Illumina (ILMN) is benefiting from sturdy demand for sequencing and array systems as well as consumables and services.
- Zacks
NuVasive (NUVA) Launches Pulse Integrated Technology Platform
The launch of this system is in sync with NuVasive's (NUVA) endeavor to deliver end-to-end solutions that offer predictable clinical and economic outcomes in spine surgery.
